Hemotherapy Supplies Iii-Automated Serology- Semi-Annual- in Commodate with Blood Bco Supply

ArgentinaTenders notice for Hemotherapy Supplies Iii-Automated Serology- Semi-Annual- in Commodate with Blood Bco Supply. The reference ID of the tender is 106470463 and it is closing on 09 Sep 2024.

100% Secure Payments

Tender Details

  • Country: Argentina
  • Summary: Hemotherapy Supplies Iii-Automated Serology- Semi-Annual- in Commodate with Blood Bco Supply
  • ART Ref No: 106470463
  • Deadline: 09 Sep 2024
  • Competition: NCB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: 266210000.00
  • Notice Type: Tender
  • Document Ref. No.: 414-1454-LPU24
  • Purchaser's Detail :
  • Purchaser : HTAL. MARIA CURIE
    Place of receipt of physical documentation: AVDA.PATRICIAS ARGENTINAS 750

  • Description :
  • SYPHILIS (V.D.R.L) . Model: Control, chemiluminescence method, HUMAN IMMUNODEFICIENCY VIRUS FOR SIMULTANEOUS DETECTION OF ANTIGEN AND ANTICU HUMAN IMMUNODEFICIENCY VIRUS FOR SIMULTANEOUS DETECTION OF ANTIGEN AND ANTICU. Model: Determination by
    See more, HEPATITIS B VIRUS (HBSAG)
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
ArgentinaTenders Features

ArgentinaTenders Features

Fresh and verified Tenders from Argentina. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Argentina in your email inbox.

  Chat with us